期刊文献+

不同超滤膜对重症脓毒症患者外周血细胞因子的影响

Effect of different ultrafiltration membrane on peripheral blood cytokine
下载PDF
导出
摘要 目的观察不同超滤膜对外周血细胞因子水平的动态变化,了解不同的膜材料对细胞因子的清除效果及作用维持时间。方法20例重症脓毒症患者随机分为两组,治疗组(10例),应用AN69膜,对照组(10例),应用PS膜,观察在连续性静脉-静脉血液滤过(CVVH)过程中0、2、4、6、8、10、12h的肿瘤坏死因子-α(TNF-α)、白介素1β(IL-1β)、白介素-6(IL-6)和白介素-8(IL-8)的水平。结果各种细胞因子水平在CVVH后2h即下降,TNF-α于治疗4h降至最低,4、6h治疗组较对照组下降更明显(P<0.05);IL-1β、IL-6、IL-86h降至最低,治疗组较对照组下降更明显(P<0.05);各种细胞因子水平于治疗12h均明显升高并接近治疗前水平。结论AN69膜及PS膜对细胞因子均有清除作用,但以AN69膜的滤器清除效果更强。对于重症脓毒症患者两者的滤器作用维持时间约为10h。 Objective To observe the effect of different ultrafiltration membrane on dynamic change of peripheral blood cytokine, to study the removal effect and lasting time of different membrane material. Methods 20 sepsis patients were randomly divided into therapy group ( 10 patients) and control group (10 patients). Therapy group were treated with AN69 membrane and control group were treated with PS membrane . Levels of TNF- α, IL- 1β, IL-6, IL-8 at 0h, 2h, 4h, 6h, 8h, 10h, 12h in the process of continuous venovenous hemofiltration (CVVH) were tested. Results Levels of all the cytokines decreased at 2h. The level of TNF - α decreased to the lowest at 4h, and it decreased more significantly in therapy group than in control group ( P 〈 0.05 ) at 4h and 6h. The levels of IL- 1β, IL- 6, IL- 8 decreased to the lowest at 6h, and they decreased more significantly in therapy group than in control group( P 〈 0.05) at that time. Levels of all cytokines increased at 12h and increased to the level before therapy. Conclusions AN69 membrane and PS membrane both have removal effects on cytokines, but the removal effect of AN69 membrane is better. Functions of both of them lasts about 10 hours in patients with severe sepsis.
出处 《浙江临床医学》 2007年第8期1038-1039,共2页 Zhejiang Clinical Medical Journal
关键词 超滤膜 连续性静脉-静脉血液滤过 重症脓毒症 细胞因子 Ultrafiltration membrane Continuous venovenous hemofiltration (CWH) Severe sepsis Cytokine
  • 相关文献

参考文献11

  • 1谢红浪,季大玺,龚德华,刘芸,徐斌,周虹,黎磊石,李维勤,全竹富,黎介寿.应用CVVH治疗重症急性胰腺炎[J].肾脏病与透析肾移植杂志,2000,9(6):510-515. 被引量:137
  • 2季大玺,谢红浪,刘芸,徐斌,任冰,龚德华,张素琴,黎磊石.连续性肾脏替代治疗在重症急性肾功能衰竭及多器官功能障碍综合征救治中的应用[J].中国危重病急救医学,1999,11(9):550-553. 被引量:76
  • 3Bone RC,Balk RA,Cerra FB.et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus conference.american college of chest physicians/society of critical care medicin.Chest,1992,101:1644-1655.
  • 4Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference.Crit Care Med,2003,31:1250-1256.
  • 5刘健,陈兵,王洪霞,马树林,阎素英,吴胜群.危重病患者SIRS期细胞因子水平与APACHE Ⅱ评分相关性研究[J].天津医药,2002,30(6):339-340. 被引量:21
  • 6Aosasa S,Ono S,Mochizuki H,et al.Mechanism of the inhibitory effect of protease inhibitor on tumer necrosis factor alpha production of monocytes.Shock,2001,15:101-105.
  • 7Bouman CS,Van-Olden RW,Stoutenbeek CP.Cytokine filtration and adsorption during pre-and post-dilution hemofiltration in four different membranes.Blood Purif,1998,16(5):261-268.
  • 8de Vriese AS,Colardyn FA,Philippe JJ,et al.Cytokine removal during continuous hemofiltration in septic patients,J Am Soc Nephrol,1999,10(4):846-853.
  • 9Fujimori A,Naito H,Miyazaki T.Adsorption of complement,cytokines,and proteins by different dialysis membrane materials:evaluation by confocal laser scanning fluorescence microscopy.Artif Organs,1998,22(12):1014-1017.
  • 10Rogiers P,Zhang H,Pauwels D,et al.Comparison of polyacrylonitrile(AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.Crit Care Med,2003,31(4):1219-1225.

二级参考文献16

  • 1吴恒义,苏磊,宋新明,卢勇,白涛.创伤性成人呼吸窘迫综合征的诊治体会[J].中国危重病急救医学,1995,7(5):276-278. 被引量:26
  • 2叶任高 谢桐.急性肾功能衰竭诊断标准[J].新医学,1983,14:2-2.
  • 3Bone RC.Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome(SIRS) and the multiple organ dysfunction syndrome(MODS)[].Annals of Internal Medicine.1996
  • 4Nathens AB,Marshall JC.Sepsis, SIRS and MODS: what is in a name[].World Journal of Surgery.1996
  • 5Ruetten H,Thiemermann C.Combination immunotherapy which neutralises the effect of TNF alpha and IL-1 beta attenuates the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat[].Journal of Physiology and Pharmacology.1997
  • 6Walter L,Emest E,Frederick A,et al.Interleukin-6 in the injured patient[].Annals of Surgery.1996
  • 7Terregino C A,Quinn J V,Slotman G J.Pilot study of cytokines in emergency department patients with systemic inflammatory response syndrome[].Academic Emergency Medicine.1997
  • 8Knaus WA,Draper FA,Wagner DP,et al.APACHE II: a severity of disease classification system[].Critical Care Medicine.1985
  • 9Bone RC,Balk RA,Cerra FB,et al.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[].Critical Care Medicine.1992
  • 10Amy M,Anthony J,Howard A,et al.Cytokines and actue pancreatitis[].Gastroenterology.1996

共引文献362

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部